Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort - Steinebrunner, N; Sprinzl, M F; Zimmermann, T (BMC Gastroenterol, 2015)
et al.